Healthcare - Biotechnology - NASDAQ - DE
$ 3.48
-4.66 %
$ 53 M
Market Cap
-0.63
P/E
Price Target
Average
115.52%
Revenue Forecast
Estimate
80.65%
EBIT
Estimate
4.66%
Net Income
Estimate
30.67%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Affimed N.V.
Wall Street analysts predict an average 1-year price target for AFMD of $7.5 , with forecasts ranging from a low of $5 to a high of $10 .
AFMD Lowest Price Target
Wall Street Target
5 USD
43.68%
AFMD Average Price Target
Wall Street Target
7.5 USD
115.52%
AFMD Highest Price Target
Wall Street Target
10 USD
187.36%
REVENUE FORECAST
Revenue Forecast Chart AFMD
EBIT FORECAST
EBIT Forecast Chart AFMD
NET INCOME FORECAST
Net Income Chart AFMD